NJ A6184

Requires general acute care hospitals to report prescription drug pricing data to the Division of Consumer Affairs, including minimum and maximum prices paid, volume dispensed, rebates received, and net income for specified drugs and drug groups

Hospitals must submit reports within 60 days after receiving annual notification from the Division identifying which drugs require reporting

Adds hospitals to the list of "reporting entities" under existing prescription drug transparency law (P.L.2023, c.106), subjecting them to the same registration requirements, annual assessments, and civil penalties for non-compliance

Non-compliance penalties range from $10,000 for the first day of violation, increasing by $1,000 per additional day of non-compliance, up to a maximum of $100,000 per day

Takes effect on the first day of the 13th month following enactment, with reported data kept confidential and used by the Division to study and report on prescription drug pricing trends in hospitals